Free tool
Heavily traded stocks
We cover 398 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.45B. Across the group, the median move over the past trading day is −0.29%. 61% of the 394 with a 200-day average trade above it. Price change over the past year runs from −31.1% to +126.2% across the middle 80 percent of the group, with a median of +12.1%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
398 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| GSK | GSK plc | $104.29B | Large cap | +32.23% |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.12% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +28.99% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +11.19% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| 4507.T | Shionogi & Co., Ltd. | $15.45B | Large cap | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| 4DX.AX | 4DMedical Limited | $1.59B | Small cap | +669.79% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $1.03B | Small cap | −9.51% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | $753.78M | Small cap | +539.50% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.42M | Small cap | +7.74% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| 9267.T | Genky DrugStores Co., Ltd. | $706.67M | Small cap | −20.07% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $638.45M | Small cap | −16.94% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| 6197.T | Solasto Corporation | $635.28M | Small cap | +136.68% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| 3034.T | Qol Holdings Co., Ltd. | $588.82M | Small cap | +24.35% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | $574.42M | Small cap | +3.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| 003850.KS | Boryung Corporation | $547.03M | Small cap | +9.00% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| 2664.T | Cawachi Limited | $531.16M | Small cap | +38.25% |
| 137310.KS | SD Biosensor, Inc. | $525.90M | Small cap | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | $525.82M | Small cap | −27.35% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $517.68M | Small cap | −40.58% |
| 7979.T | Shofu Inc. | $517.24M | Small cap | +21.34% |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% |
| 3151.T | Vital KSK Holdings, Inc. | $501.27M | Small cap | +40.44% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −5.16% |
| 317450.KS | MYUNGIN PHARM | $482.84M | Small cap | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| 005690.KS | Pharmicell Co., Ltd. | $472.85M | Small cap | −0.03% |
| 001060.KS | JW Pharmaceutical Corporation | $456.57M | Small cap | +26.96% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | $425.58M | Small cap | −15.77% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $422.50M | Small cap | −19.86% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $397.43M | Small cap | +27.04% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | $381.70M | Small cap | −10.08% |
| 368A.T | KITAZATO CORPORATION | $374.26M | Small cap | −1.33% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | $366.01M | Small cap | −13.02% |
| 262A.T | INTERMESTIC INC | $357.38M | Small cap | −28.96% |
| 3733.T | Software Service, Inc. | $356.91M | Small cap | −14.23% |
| OPT.L | Optima Health plc | $355.51M | Small cap | +9.32% |
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −30.13% |
| 377740.KS | BioNote, Inc. | $346.63M | Small cap | −13.05% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | $341.88M | Small cap | −30.36% |
| 197A.T | TAUNS LABORATORIES INC. | $338.11M | Small cap | −11.13% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | $329.08M | Small cap | −40.38% |
| 005250.KS | GC Corp. | $328.80M | Small cap | −32.75% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| 7779.T | CYBERDYNE Inc. | $307.38M | Small cap | +12.08% |
| 4554.T | Fuji Pharma Co., Ltd. | $302.90M | Small cap | +26.29% |
| 4894.T | Cuorips Inc. | $300.07M | Small cap | −15.38% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $294.43M | Small cap | +26.14% |
| 0120G0.KS | Samyang Biopharm | $292.45M | Small cap | +79.14% |
| 7777.T | 3-D Matrix, Ltd. | $289.93M | Small cap | +68.69% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| 6078.T | Value HR Co.,Ltd. | $273.03M | Small cap | +6.39% |
| 950210.KS | Prestige BioPharma Limited | $268.90M | Small cap | −55.91% |
| 4820.T | EM Systems Co., Ltd. | $262.55M | Small cap | −18.79% |
| 170900.KS | Dong-A ST Co., Ltd. | $261.59M | Small cap | −10.09% |
| 6823.T | Rion Co., Ltd. | $257.99M | Small cap | +29.62% |
| 7071.T | Amvis Holdings, Inc. | $254.26M | Small cap | −31.35% |
| 4548.T | Seikagaku Corporation | $247.39M | Small cap | +13.11% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | $244.15M | Small cap | +14.45% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −41.63% |
| 6062.T | Charm Care Corporation | $235.18M | Small cap | +33.46% |
| 145720.KS | Dentium CO., LTD | $231.74M | Small cap | −35.04% |
| 3183.T | WIN-Partners Co., Ltd. | $219.85M | Small cap | −0.56% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $216.10M | Small cap | +75.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | $207.18M | Small cap | +11.63% |
| 7679.T | YAKUODO HOLDINGS Co., Ltd. | $204.33M | Small cap | −25.53% |
| 096760.KS | JW Holdings Corporation | $202.71M | Small cap | +28.35% |
| 9273.T | Koa Shoji Holdings Co.,Ltd. | $202.46M | Small cap | +0.52% |
| 5592.T | Kusurinomadoguchi, Inc. | $191.48M | Small cap | −27.59% |
| 286A.T | EUCALIA INC | $181.85M | Small cap | −10.77% |
| 5038.T | eWeLL Co.,Ltd. | $181.33M | Small cap | −22.27% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| 008490.KS | Suheung Co., Ltd. | $179.47M | Small cap | −24.62% |
| 4320.T | CE Holdings Co.,Ltd. | $172.87M | Small cap | +139.84% |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | $168.08M | Small cap | +0.32% |
| 504A.T | Innovacell Inc. | $162.36M | Small cap | −45.71% |
| 3939.T | Kanamic Network Co.,LTD | $154.86M | Small cap | +6.05% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | $150.88M | Small cap | −43.89% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | $135.03M | Small cap | +51.26% |
| 001630.KS | Chong Kun Dang Holdings Corp. | $134.30M | Small cap | −17.31% |
| 7600.T | Japan Medical Dynamic Marketing, INC. | $134.12M | Small cap | +59.26% |
| 016580.KS | Whan In Pharm Co.,Ltd. | $133.88M | Small cap | −5.20% |
| 9158.T | CUC Inc. | $132.27M | Small cap | −37.22% |
| 102460.KS | REYON Pharmaceutical Co., Ltd. | $131.78M | Small cap | −8.36% |
| 3649.T | FINDEX Inc. | $131.51M | Small cap | +4.84% |
| 234080.KS | JW Lifescience Corporation | $124.49M | Small cap | +1.24% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | $123.47M | Small cap | +11.15% |
| 003220.KS | Daewon Pharmaceutical Co., Ltd. | $121.47M | Small cap | −39.54% |
| 3154.T | Medius Holdings Co., Ltd. | $112.89M | Small cap | −2.42% |
| 4889.T | Renascience Inc. | $112.48M | Small cap | −40.80% |
| 2929.T | Pharma Foods International Co., Ltd. | $112.09M | Small cap | −37.82% |
| 007570.KS | Ilyang Pharmaceutical Co.,Ltd | $108.28M | Small cap | −32.69% |
| 3544.T | Satudora Holdings Co.,Ltd. | $108.01M | Small cap | +51.42% |
| 003120.KS | Ilsung Is Co., Ltd. | $107.90M | Small cap | −4.68% |
| 293480.KS | Hana Pharm Co., Ltd. | $107.44M | Small cap | −27.02% |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $106.51M | Small cap | −26.59% |
| 4575.T | CanBas Co., Ltd. | $103.86M | Small cap | −30.98% |
| 000020.KS | Dongwha Pharm.Co.,Ltd | $103.19M | Small cap | −17.95% |
| 7743.T | SEED Co.,Ltd. | $101.61M | Small cap | +0.58% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.